DexTech Medical AB (FRA:LQ0) Receivables Turnover: (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:LQ0 DexTech Medical AB FRA:LQ0
30 GF Score
Price €0.79
! 2 Warning Signs
View Full Analysis

What is DexTech Medical AB Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. DexTech Medical AB's Revenue for the three months ended in Jun. 2026 was €0.00 Mil. DexTech Medical AB's average Accounts Receivable for the three months ended in Jun. 2026 was €0.00 Mil.

DexTech Medical AB  (FRA:LQ0) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

DexTech Medical AB Receivables Turnover Related Terms

DexTech Medical AB Receivables Turnover Historical Data

* Premium members only.

The historical data trend for DexTech Medical AB's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DexTech Medical AB Receivables Turnover Chart

DexTech Medical AB Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25 Jun26
Receivables Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

DexTech Medical AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

FRA:LQ0 vs VRTX, REGN, MRNA: Receivables Turnover Comparison

For the Biotechnology subindustry, DexTech Medical AB's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DexTech Medical AB Receivables Turnover vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, DexTech Medical AB's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where DexTech Medical AB's Receivables Turnover falls into.


FRA:LQ0
30GF Score
DexTech Medical AB FRA:LQ0
Receivables Turnover is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DexTech Medical AB Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

DexTech Medical AB's Receivables Turnover for the fiscal year that ended in Jun. 2026 is calculated as

Receivables Turnover (A: Jun. 2026 )
=Revenue / Average Accounts Receivable
=Revenue (A: Jun. 2026 ) / ((Accounts Receivable (A: Jun. 2025 ) + Accounts Receivable (A: Jun. 2026 )) / count )
=0 / (( + ) / 1 )
=0 / 0
=N/A

DexTech Medical AB's Receivables Turnover for the quarter that ended in Jun. 2026 is calculated as

Receivables Turnover (Q: Jun. 2026 )
=Revenue / Average Accounts Receivable
=Revenue (Q: Jun. 2026 ) / ((Accounts Receivable (Q: Mar. 2026 ) + Accounts Receivable (Q: Jun. 2026 )) / count )
=0 / (( + ) / 1 )
=0 / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DexTech Medical AB Business Description

Other Exchanges DEX:Sweden
Address Dag Hammarskjolds Vag 34A, Uppsala, SWE, 752 37
DexTech Medical AB is a Swedish research company specializing in drug development for urological oncology, with a prominent focus on prostate cancer. The company develops drug candidates using a proprietary carbohydrate platform, advancing treatments aimed at castration-resistant prostate cancer and related conditions. Its operations center on research, development, and licensing of these drug candidates. It has four drug candidates: OsteoDex, SomaDex, PSMA-binding conjugates, and GuaDex.
30GF Score

Get the complete analysis for FRA:LQ0

Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.79
Price